|
|
Article: Opexa to Present at the Merriman Curhan Ford 6th Annual Investor Summit 2009 on November 10, 2009.
- Article from:
- Business Wire
- Article date:
- November 5, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin([R]), a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that Neil K. Warma, Opexa's president and chief executive officer, will deliver a corporate presentation at the Merriman Curhan Ford 6th Annual Investor Summit 2009. The conference will be held November 9-10, 2009, at the Sofitel New York Hotel in New York City.
Opexa's presentation will occur at 4:40 p.m. (EST) on Tuesday, November 10, 2009 and will include an overview of the company's ongoing clinical development program for Tovaxin, the company's lead therapy for MS. The presentation ...
Related newspaper, magazine, and journal articles:
|
|
Article: Opexa Therapeutics Presents Myelin Reactive T-Cell ...
Business Wire;
May 22, 2008 ;
700+ words
...THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved ... patients treated in earlier clinical studies. About Opexa Therapeutics Opexa Therapeutics develops and commercializes cell therapies to treat ...
|
|